We’re proud to once again be ranked in the top five of Americas Most Just companies in biopharma. The honor reflects our ongoing commitment to operate responsibly and empower our employees to help create a healthier world for all.
In recognition of Women's History Month, our Identity + Innovation spotlight features Devi SenGupta. Hear how Devi's background has shaped her approach to developing new medicines and to bringing Gilead closer to a cure for HIV.
Lauren Huffmaster received a late-stage metastatic breast cancer (mBC) diagnosis in 2015 and soon discovered there wasn’t a lot information to help explain to her young children what she was going through.
Each scientific discovery gets us one step closer to our shared goal of ending the HIV epidemic. As a leader in HIV treatment and prevention, we’ll continue to build on our legacy and create innovative solutions to address the diverse needs of all people affected by HIV.
As a nation where 90% of all people living with HIV know their diagnosis and are being treated, Germany has made great strides to advance its HIV care goals.
Read more to discover how Ashley has been able to broaden her impact on the HIV epidemic while working in an environment where she feels comfortable being her full, authentic self.
Listen to episode 2 of our Hepcast as we follow the journey of a young man living with HepatitisB. He’s joined by Arafat Bwambale from the Great Lakes Peace Centre in Uganda and Manal El Sayed from Ain Shams University in Egypt.
The Social Justice Experience is a virtual, interactive platform that examines the Black American experience with a timeline of Black history in America dating back to 1619.
Dr. Sara Tolaney oversees an independent and diverse scientific review committee composed of experts in oncology who review all applications and select who will receive funding. Diversity is at the forefront of her mind.
Congratulations to Michael Elliott, Vice President of Development and Medical Affairs at Gilead, for being named to this year's Empower Advocate Executive Role Model List.
We’re pleased to announce that we're joining the global Access to Oncology Medicines (ATOM) Coalition to help improve care and access to essential cancer medicines in low- and lower middle-income countries.
“Gilead's support for community organizations is part of our enduring commitment to ending the HIV epidemic,” said Daniel O’Day, Chairman and Chief Executive Officer, Gilead Sciences.
Gilead’s Corporate Social Responsibility (CSR) Report provides an overview of the work the company is doing around the world to improve the lives of...